article thumbnail

Flu Vaccines Are a Go

Pharmacy Times

link] Download Issue PDF Download RIS Articles in this issue Flu Vaccines Are a Go Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. February 25, 2025. Accessed June 30, 2025.

article thumbnail

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Pharmacy Times

Pharmacy Times. ASCO 2025: insights on NALIRIFOX use in metastatic pancreatic ductal adenocarcinoma from the NAPOLI-3 trial. June 5, 2025. Accessed June 23, 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

Pharmacy Times

Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology. Commun Med (Lond). 2022;2(1):154.

article thumbnail

The Changing Landscape of Pharmacy Accessibility

Pharmacy Times

Health Aff Sch. 2024;2(4):qxae035. doi:10.1093/haschl/qxae035 Baldoni S, Amenta F, Ricci G. Telepharmacy services: present status and future perspectives: a review. Medicina (Kaunas). 2019;55(7):327.doi:10.3390/medicina55070327

article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

Acalabrutinib plus bendamustine and rituximab may become new standard care for untreated MCL. Cancer Therapy Advisor. June 21, 2024. Accessed March 16, 2025.

article thumbnail

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Pharmacy Times

link] Download Issue PDF Download RIS Articles in this issue Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season Flu Vaccines Are a Go Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. November 7, 2022.

article thumbnail

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)